← Leaderboards
Wei-Qi Wei
Vanderbilt University Medical Center
$9,737,275
Attributed
$18,267,677
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,884,581 · 10
By mechanism
R01$9,973,969 · 5
U01$6,210,639 · 1
P50$3,825,431 · 3
R56$874,542 · 1
Top collaborators
- Dan M Roden7 shared
- Digna R Velez Edwards6 shared
- Bingshan Li5 shared
- Zhexing Wen5 shared
- Qiping Feng4 shared
- Elizabeth Phillips1 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Dan M Roden$145,793,078
- Christopher J. Lindsell$13,699,189
- Jonathan Dale Casey$4,195,060
- Margaret McCullough Benningfield$498,339
- Sarah Kelly McGill$1,033,979
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposElectronic Health RecordPharmaceutical PreparationsPhenotypeValidationGenome Wide Association StudyBiobankData SetAlgorithmsCohortResourcesNatural Language ProcessingSitePhenotyping AlgorithmGeneticLinkPhenomeHeritabilityInformaticsGenotypeElectronic Medical Records And Genomics NetworkResearch PersonnelResponseHealthcare
Grant awards (30)
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias$874,857
R01 · FY2025 · AG · contact PI
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data$861,667
R01 · FY2025 · HL · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$762,918
R01 · FY2025 · AG
Phenotyping Support Core$242,190
P50 · FY2025 · HD · contact PI
Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data$874,792
R01 · FY2024 · HL · contact PI
Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias$874,542
R56 · FY2024 · AG · contact PI
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$779,465
R01 · FY2024 · AG
Vanderbilt Genome-Electronic Records (VGER) Project$749,397
U01 · FY2024 · HG
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping$432,500
R01 · FY2024 · GM · contact PI
Phenotyping Support Core$239,766
P50 · FY2024 · HD · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$1,367,395
U01 · FY2023 · HG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$789,918
R01 · FY2023 · AG
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping$432,500
R01 · FY2023 · GM · contact PI
Phenotyping Support Core$242,190
P50 · FY2023 · HD · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$106,629
U01 · FY2023 · HG
Vanderbilt Genome-Electronic Records (VGER) Project$1,448,100
U01 · FY2022 · HG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$799,966
R01 · FY2022 · AG
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping$432,500
R01 · FY2022 · GM · contact PI
Phenotyping Support Core$242,190
P50 · FY2022 · HD · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$1,448,100
U01 · FY2021 · HG
Drug repositioning for Alzheimer's disease via genetics, electronic health records, and human iPSC models$838,304
R01 · FY2021 · AG
PheMAP: Measured, Automated Profile to Facilitate High Throughput Phenotyping$432,500
R01 · FY2021 · GM · contact PI
Phenotyping Support Core$242,191
P50 · FY2021 · HD · contact PI
Vanderbilt Genome-Electronic Records (VGER) Project$1,091,018
U01 · FY2020 · HG
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort$395,483
R01 · FY2020 · HL · contact PI
Improving Prediction of Drug Action$2,616,904
P50 · FY2019 · GM
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort$410,983
R01 · FY2019 · HL · contact PI
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort$399,573
R01 · FY2018 · HL · contact PI
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort - Diversity Supplement$49,920
R01 · FY2018 · HL · contact PI
Exploring Statin Pleiotropic Effects within a Very Large EHR Cohort$406,123
R01 · FY2017 · HL · contact PI